Showing results (61-70 of 2,507) with videos related to

Sort By:
Pageof 251
Clinical Lymphoma, Myeloma & Leukemia|October 7, 2015
Efficacy of Azacitidine in De Novo and Relapsed Acute Myeloid Leukemia: A Retrospective Comparative StudyCornelia Gemuenden, Rudolf Benz, Oliver Senn, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 14, 2013
A post hoc sensitivity analysis of survival probabilities in a multinational phase III trial of decitabine in older patients with newly diagnosed acute myeloid leukemiaXavier G Thomas, Christopher Arthur, Jacques Delaunay, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 9, 2013
The prognostic significance of elevated levels of serum ferritin before chemotherapy in patients with non-Hodgkin lymphomaKyung Ah Yoh, Ho Sup Lee, Lee Chun Park, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 18, 2011
Incidence rates and risk factors for vascular events in patients with essential thrombocythemia: a multicenter study from KoreaHo Sup Lee, Lee Chun Park, Eun Mi Lee, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 21, 2013
A comparison of long-term outcomes of donor lymphocyte infusions and tyrosine kinase inhibitors in patients with relapsed CML after allogeneic hematopoietic cell transplantationMohamed Shanavas, Hans A Messner, Suzanne Kamel-Reid, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 5, 2012
A randomized controlled trial of an intensive insulin regimen in patients with hyperglycemic acute lymphoblastic leukemiaKhanh Vu, Naifa Busaidy, Maria E Cabanillas, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 19, 2015
Systemic Mastocytosis: Clinical Update and Future DirectionsDouglas Tremblay, Nicole Carreau, Marina Kremyanskaya, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 31, 2016
Clinical Features and Treatment Outcomes of Patients With Necrobiotic Xanthogranuloma Associated With Monoclonal GammopathiesLarissa S Higgins, Ronald S Go, David Dingli, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 2, 2016
Autologous Stem Cell Mobilization in the Age of PlerixaforDennis L Cooper, Erin Medoff, Natalie Patel, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 2, 2016
Comparison of Branded and Generic Imatinib Plasma Concentrations in Patients With Chronic Myelogenous Leukemia: Unicentric StudyAlen Ostojic, Dubravka Sertic, Pavle Roncevic, et al.
Pageof 251